Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients

被引:101
作者
McMillan, DC [1 ]
Scott, HR
Watson, WS
Preston, T
Milroy, R
McArdle, CS
机构
[1] Univ Glasgow, Royal Infirm, Dept Surg, Glasgow G31 2ER, Lanark, Scotland
[2] Stobhill Natl Hlth Serv Trust, Dept Resp Med, Glasgow G21 3UW, Lanark, Scotland
[3] So Gen Natl Hlth Serv Trust, Dept Nucl Med, Glasgow G51 4TF, Lanark, Scotland
[4] Scottish Univ Res & Reactor Ctr, Isotope Biochem Lab, E Kilbride G75 0QU, Lanark, Scotland
来源
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | 1998年 / 31卷 / 02期
关键词
D O I
10.1080/01635589809514687
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
There is recent evidence that the inflammatory response may be important in the disproportionate loss of body cell mass in cancer patients. To examine this further, 18 male patients with lung or gastrointestinal cancer were studied over a 12-week-period. In addition to weight, anthropometry, C-reactive protein (marker of the inflammatory response), albumin, and total body potassium were measured at baseline and 12 weeks. When those patients who lost total body potassium were compared with those who had not, there was a significant increase in the baseline and 12-week C-reactive protein concentrations (p < 0.05). The reduction in total body potassium was also associated with a reduction in triceps skinfold thickness (p < 0.05). There were significant correlations between the mean C-reactive protein concentration and the relative (r = -0.846 p < 0.001) and absolute (r = -0.806 p < 0.001) change in total body potassium over the follow-up period This study demonstrates the association of a chronic inflammatory response with the rate of loss of body cell mass observed in cancer patients.
引用
收藏
页码:101 / 105
页数:5
相关论文
共 23 条
[1]   RELATION OF TOTAL-BODY POTASSIUM TO HEIGHT, WEIGHT, AND AGE IN NORMAL ADULTS [J].
BODDY, K ;
HUME, R ;
WEYERS, E ;
KING, PC .
JOURNAL OF CLINICAL PATHOLOGY, 1972, 25 (06) :512-&
[2]   COMPARTMENTAL BODY-COMPOSITION OF CANCER-PATIENTS BY MEASUREMENT OF TOTAL-BODY NITROGEN, POTASSIUM, AND WATER [J].
COHN, SH ;
GARTENHAUS, W ;
SAWITSKY, A ;
RAI, K ;
ZANZI, I ;
VASWANI, A ;
ELLIS, KJ ;
YASUMURA, S ;
CORTES, E ;
VARTSKY, D .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1981, 30 (03) :222-229
[3]   ALBUMIN STANDARDS AND MEASUREMENT OF SERUM ALBUMIN WITH BROMCRESOL GREEN [J].
DOUMAS, BT ;
WATSON, WA ;
BIGGS, HG .
CLINICA CHIMICA ACTA, 1971, 31 (01) :87-&
[4]   CYTOKINES, THE ACUTE-PHASE RESPONSE, AND RESTING ENERGY-EXPENDITURE IN CACHECTIC PATIENTS WITH PANCREATIC-CANCER [J].
FALCONER, JS ;
FEARON, KCH ;
PLESTER, CE ;
ROSS, JA ;
CARTER, DC .
ANNALS OF SURGERY, 1994, 219 (04) :325-331
[5]   ELEVATED CIRCULATING INTERLEUKIN-6 IS ASSOCIATED WITH AN ACUTE-PHASE RESPONSE BUT REDUCED FIXED HEPATIC PROTEIN-SYNTHESIS IN PATIENTS WITH CANCER [J].
FEARON, KCH ;
MCMILLAN, DC ;
PRESTON, T ;
WINSTANLEY, FP ;
CRUICKSHANK, AM ;
SHENKIN, A .
ANNALS OF SURGERY, 1991, 213 (01) :26-31
[6]   Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response [J].
Fearon, KCH ;
Falconer, JS ;
Slater, C ;
McMillan, DC ;
Ross, JA ;
Preston, T .
ANNALS OF SURGERY, 1998, 227 (02) :249-254
[7]   Progressive cellular dehydration and proteolysis in critically ill patients [J].
Finn, PJ ;
Plank, LD ;
Clark, MA ;
Connolly, AB ;
Hill, GL .
LANCET, 1996, 347 (9002) :654-656
[8]   BODY-COMPOSITION IN MALIGNANT DISEASE [J].
MACFIE, J ;
BURKINSHAW, L .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1987, 36 (03) :290-294
[9]   A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients [J].
McMillan, DC ;
OGorman, P ;
Fearon, KCH ;
McArdle, CS .
BRITISH JOURNAL OF CANCER, 1997, 76 (06) :788-790
[10]  
MCMILLAN DC, 1994, NUTRITION, V10, P232